---
figid: PMC9099194__WJG-28-1781-g001
pmcid: PMC9099194
image_filename: WJG-28-1781-g001.jpg
figure_link: /pmc/articles/PMC9099194/figure/F1/
number: Figure 1
figure_title: ''
caption: 'Expression and prognosis of forkhead Box q1 and heparin binding epidermal
  growth factor in colorectal cancer and normal colorectal tissues. A and B: Forkhead
  Box q1 (FOXQ1) (left) and heparin binding epidermal growth factor (HB-EGF) (right)
  expression was analyzed in human colorectal cancer (CRC) tissues and normal tissues
  using the Gene Expression Profiling Interactive Analysis online database. aP < 0.05;
  C and D: Overall survival rate of FOXQ1 (left) and HB-EGF (right) in CRC patients.
  FOXQ1: Forkhead Box q1; HB-EGF: Heparin binding epidermal growth factor; GEPIA:
  Gene Expression Profiling Interactive Analysis.'
article_title: Forkhead Box q1 promotes invasion and metastasis in colorectal cancer
  by activating the epidermal growth factor receptor pathway.
citation: Jin-Jin Zhang, et al. World J Gastroenterol. 2022 May 7;28(17):1781-1797.
year: '2022'

doi: 10.3748/wjg.v28.i17.1781
journal_title: World Journal of Gastroenterology
journal_nlm_ta: World J Gastroenterol
publisher_name: Baishideng Publishing Group Inc

keywords:
- Colorectal cancer
- Forkhead Box Q1
- Heparin binding epidermal growth factor
- Epidermal growth factor receptor pathway
- Migration
- Invasion

---
